BMRN vs SLP · P/E 40, rev $1.76B vs rev $79.2M
Biomarin Pharmaceutical Inc (BMRN) versus Simulations Plus Inc (SLP) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Simulations Plus Inc (SLP) is a health information services company listed on NASDAQ.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported SLP revenue for 2025-08-31 was $79.2M. Net income was -$64.7M. SLP currently screens at market cap $368.8M.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. SLP currently screens at market cap $368.8M.
Not investment advice. Open the BMRN and SLP stock pages for the full models.
Not investment advice.